1 false false false false false false false false false false true false false false false false false No description of principal activity 2024-01-01 Sage Accounts Production Advanced 2023 - FRS102_2023 xbrli:pure xbrli:shares iso4217:GBP 11117811 2024-01-01 2024-12-31 11117811 2024-12-31 11117811 2023-12-31 11117811 2023-01-01 2023-12-31 11117811 2023-12-31 11117811 2022-12-31 11117811 bus:Director1 2024-01-01 2024-12-31 11117811 core:WithinOneYear 2023-12-31 11117811 bus:Micro-entities 2024-01-01 2024-12-31 11117811 bus:AuditExemptWithAccountantsReport 2024-01-01 2024-12-31 11117811 bus:SmallCompaniesRegimeForAccounts 2024-01-01 2024-12-31 11117811 bus:PrivateLimitedCompanyLtd 2024-01-01 2024-12-31 11117811 bus:FullAccounts 2024-01-01 2024-12-31
COMPANY REGISTRATION NUMBER: 11117811
Neuron Consulting Ltd.
Filleted Unaudited Financial Statements
31 December 2024
Neuron Consulting Ltd.
Statement of Financial Position
31 December 2024
2024
2023
£
£
Fixed assets
214
868
----
----
Current assets
70,325
111,536
Creditors: amounts falling due within one year
–
21,820
--------
---------
Net current assets
70,325
89,716
--------
--------
Total assets less current liabilities
70,539
90,584
Accruals and deferred income
2,340
3,354
--------
--------
68,199
87,230
--------
--------
Capital and reserves
68,199
87,230
--------
--------
Notes to the financial statements
1. Employee numbers
The average number of persons employed by the company during the year amounted to 1 (2023: 1 ).
2. Director's advances, credits and guarantees
The directors loan account is not disclosed as permitted under FRS 105.
For the year ending 31 December 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 24 September 2025 , and are signed on behalf of the board by:
Dr P Bhogal
Director
Company registration number: 11117811
The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Flat 26 Imperial Hall, 104-122 City Road, Islington, EC1V 2NR.